211 related articles for article (PubMed ID: 34799634)
1. Cuprizone feed formulation influences the extent of demyelinating disease pathology.
Toomey LM; Papini M; Lins B; Wright AJ; Warnock A; McGonigle T; Hellewell SC; Bartlett CA; Anyaegbu C; Fitzgerald M
Sci Rep; 2021 Nov; 11(1):22594. PubMed ID: 34799634
[TBL] [Abstract][Full Text] [Related]
2. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
Nomura T; Bando Y; You H; Tanaka T; Yoshida S
Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO
Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte ablation induced by La-aminoadipate (L-AAA) potentiates remyelination in a cuprizone demyelinating mouse model.
Madadi S; Pasbakhsh P; Tahmasebi F; Mortezaee K; Khanehzad M; Boroujeni FB; Noorzehi G; Kashani IR
Metab Brain Dis; 2019 Apr; 34(2):593-603. PubMed ID: 30652255
[TBL] [Abstract][Full Text] [Related]
5. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
6. The effects of a combination of ion channel inhibitors on pathology in a model of demyelinating disease.
Gopalasingam G; Bartlett CA; McGonigle T; Majimbi M; Warnock A; Ford A; Gough A; Toomey LM; Fitzgerald M
Mult Scler Relat Disord; 2019 Sep; 34():1-8. PubMed ID: 31202958
[TBL] [Abstract][Full Text] [Related]
7. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y
Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of minocycline on cuprizone induced cortical demyelination.
Skripuletz T; Miller E; Moharregh-Khiabani D; Blank A; Pul R; Gudi V; Trebst C; Stangel M
Neurochem Res; 2010 Sep; 35(9):1422-33. PubMed ID: 20544279
[TBL] [Abstract][Full Text] [Related]
9. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
Hiremath MM; Saito Y; Knapp GW; Ting JP; Suzuki K; Matsushima GK
J Neuroimmunol; 1998 Dec; 92(1-2):38-49. PubMed ID: 9916878
[TBL] [Abstract][Full Text] [Related]
10. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Steelman AJ; Thompson JP; Li J
Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
[TBL] [Abstract][Full Text] [Related]
11. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
Binder MD; Cate HS; Prieto AL; Kemper D; Butzkueven H; Gresle MM; Cipriani T; Jokubaitis VG; Carmeliet P; Kilpatrick TJ
J Neurosci; 2008 May; 28(20):5195-206. PubMed ID: 18480276
[TBL] [Abstract][Full Text] [Related]
12. The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis.
Kipp M; Norkus A; Krauspe B; Clarner T; Berger K; van der Valk P; Amor S; Beyer C
Inflamm Res; 2011 Aug; 60(8):723-6. PubMed ID: 21516513
[TBL] [Abstract][Full Text] [Related]
13. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12/IL-17/IL-11 axis and restriction of mature oligodendrocytes apoptosis.
Sanadgol N; Golab F; Tashakkor Z; Taki N; Moradi Kouchi S; Mostafaie A; Mehdizadeh M; Abdollahi M; Taghizadeh G; Sharifzadeh M
Pharm Biol; 2017 Dec; 55(1):1679-1687. PubMed ID: 28447514
[TBL] [Abstract][Full Text] [Related]
15. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
16. Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.
Hochstrasser T; Exner GL; Nyamoya S; Schmitz C; Kipp M
J Mol Neurosci; 2017 Apr; 61(4):617-624. PubMed ID: 28238065
[TBL] [Abstract][Full Text] [Related]
17. Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination.
Yu H; Wu M; Lu G; Cao T; Chen N; Zhang Y; Jiang Z; Fan H; Yao R
Brain Res; 2018 Jan; 1678():75-84. PubMed ID: 29038005
[TBL] [Abstract][Full Text] [Related]
18. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
19. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
El-Etr M; Rame M; Boucher C; Ghoumari AM; Kumar N; Liere P; Pianos A; Schumacher M; Sitruk-Ware R
Glia; 2015 Jan; 63(1):104-17. PubMed ID: 25092805
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of oligomeric proanthocyanidin in cuprizone-induced demyelination.
Wang Q; Wang J; Yang Z; Sui R; Miao Q; Li Y; Yu J; Liu C; Zhang G; Xiao B; Ma C
Exp Physiol; 2019 Jun; 104(6):876-886. PubMed ID: 30811744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
